Healthcare provider profile · identity verified

Bryan Richard Conklin, MD PC

Family Practice · LA GRANDE, OR · NPI 1346334075

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	626	97
Atorvastatin Calcium	Atorvastatin Calcium	366	75
Lisinopril	Lisinopril	357	76
Omeprazole	Omeprazole	278	57
Amlodipine Besylate	Amlodipine Besylate	244	53
Gabapentin	Gabapentin	191	34
Metoprolol Tartrate	Metoprolol Tartrate	184	44
Losartan Potassium	Losartan Potassium	162	44
Warfarin Sodium	Warfarin Sodium	145	18
Metformin Hcl Er	Metformin Hcl	140	32
Citalopram Hbr	Citalopram Hydrobromide	137	23
Albuterol Sulfate Hfa	Albuterol Sulfate	136	42
Furosemide	Furosemide	134	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	132	27
Metformin Hcl	Metformin Hcl	128	32
Pantoprazole Sodium	Pantoprazole Sodium	117	18
Simvastatin	Simvastatin	117	24
Alendronate Sodium	Alendronate Sodium	104	26
Potassium Chloride	Potassium Chloride	100	20
Trazodone Hcl	Trazodone Hcl	96	15
Sertraline Hcl	Sertraline Hcl	93	15
Spironolactone	Spironolactone	93	20
Tamsulosin Hcl	Tamsulosin Hcl	90	20
Hydrochlorothiazide	Hydrochlorothiazide	89	19
Eliquis	Apixaban	84	12
Famotidine	Famotidine	83	12
Alprazolam	Alprazolam	82	18
Meloxicam	Meloxicam	82	20
Zolpidem Tartrate	Zolpidem Tartrate	80	14
Tramadol Hcl	Tramadol Hcl	79	22
Metoprolol Succinate	Metoprolol Succinate	77	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	67	suppressed
Prednisone	Prednisone	65	37
Ezetimibe	Ezetimibe	63	12
Cephalexin	Cephalexin	60	45
Fluticasone Propionate	Fluticasone Propionate	58	22
Lovastatin	Lovastatin	57	13
Gemfibrozil	Gemfibrozil	56	15
Allopurinol	Allopurinol	55	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	50	35
Duloxetine Hcl	Duloxetine Hcl	45	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	45	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Risperidone	Risperidone	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Donepezil Hcl	Donepezil Hcl	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Azithromycin	Azithromycin	37	33
Carvedilol	Carvedilol	37	suppressed
Glimepiride	Glimepiride	37	suppressed
Testosterone Cypionate	Testosterone Cypionate	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	28
Cefdinir	Cefdinir	34	29
Glipizide Er	Glipizide	34	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	33	suppressed
Methocarbamol	Methocarbamol	32	suppressed
Valacyclovir	Valacyclovir Hcl	32	15
Doxycycline Hyclate	Doxycycline Hyclate	31	25
Lorazepam	Lorazepam	31	suppressed
Oxycontin	Oxycodone Hcl	31	suppressed
Finasteride	Finasteride	30	suppressed
Ozempic	Semaglutide	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Jardiance	Empagliflozin	26	suppressed
Mupirocin	Mupirocin	26	17
Naproxen	Naproxen	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	suppressed
Topiramate	Topiramate	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Fluconazole	Fluconazole	25	16
Rizatriptan	Rizatriptan Benzoate	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	11
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Temazepam	Temazepam	22	suppressed
Methylprednisolone	Methylprednisolone	21	18
Xarelto	Rivaroxaban	21	suppressed
Levofloxacin	Levofloxacin	20	20
Amoxicillin	Amoxicillin	17	12
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	11
Ondansetron Odt	Ondansetron	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Valsartan	Valsartan	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Trandolapril	Trandolapril	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Baclofen	Baclofen	12	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error